These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9493687)

  • 1. Macrolide antibiotics in diffuse panbronchiolitis and in cystic fibrosis.
    Everard ML; Sly P; Brenan S; Ryan G
    Eur Respir J; 1997 Dec; 10(12):2926. PubMed ID: 9493687
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrolide antibiotics in diffuse panbronchiolitis and in cystic fibrosis.
    Spencer D
    Eur Respir J; 1998 Jun; 11(6):1428. PubMed ID: 9657591
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis.
    Schultz MJ
    J Antimicrob Chemother; 2004 Jul; 54(1):21-8. PubMed ID: 15190022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
    Bush A
    Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease.
    Rubin BK; Henke MO
    Chest; 2004 Feb; 125(2 Suppl):70S-78S. PubMed ID: 14872003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of peripheral airway findings using an ultrathin bronchofiberscope and bronchoalveolar lavage fluid with diffuse panbronchiolitis.
    Kikawada M; Ichinose Y; Minemura K; Takasaki M; Toyama K
    Respiration; 1998; 65(6):433-40. PubMed ID: 9817957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory effects of macrolides in lung disease.
    Jaffé A; Bush A
    Pediatr Pulmonol; 2001 Jun; 31(6):464-73. PubMed ID: 11389580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical similarities and differences between human T-cell lymphotropic virus type 1-associated bronchiolitis and diffuse panbronchiolitis.
    Kadota J; Mukae H; Fujii T; Seki M; Tomono K; Kohno S
    Chest; 2004 Apr; 125(4):1239-47. PubMed ID: 15078730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
    Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
    J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term macrolide treatment for chronic respiratory disease.
    Spagnolo P; Fabbri LM; Bush A
    Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseases.
    Garey KW; Alwani A; Danziger LH; Rubinstein I
    Chest; 2003 Jan; 123(1):261-5. PubMed ID: 12527628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis.
    Mukae H; Kadota J; Kohno S; Kusano S; Morikawa T; Matsukura S; Hara K
    Am J Respir Crit Care Med; 1995 Aug; 152(2):613-8. PubMed ID: 7633715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolides in cystic fibrosis.
    McArdle JR; Talwalkar JS
    Clin Chest Med; 2007 Jun; 28(2):347-60. PubMed ID: 17467553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic characterization of T cells in bronchoalveolar lavage fluid (BALF) and peripheral blood of patients with diffuse panbronchiolitis; the importance of cytotoxic T cells.
    Kawakami K; Kadota J; Iida K; Fujii T; Shirai R; Matsubara Y; Kohno S
    Clin Exp Immunol; 1997 Feb; 107(2):410-6. PubMed ID: 9030883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse panbronchiolitis--a case report.
    Poh SC; Wang YT; Wang WY
    Singapore Med J; 2001 Jun; 42(6):271-4. PubMed ID: 11547966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide antibiotic therapy in patients with cystic fibrosis.
    Schöni MH
    Swiss Med Wkly; 2003 May; 133(21-22):297-301. PubMed ID: 12861467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of macrolides in lung diseases: recent literature controversies.
    Silva Filho LV; Pinto LA; Stein RT
    J Pediatr (Rio J); 2015; 91(6 Suppl 1):S52-60. PubMed ID: 26354869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspectives on macrolide antibiotics.
    Pechère JC
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S93-7. PubMed ID: 11574203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of macrolides in childhood lung diseases.
    Luisi F; Gandolfi TD; Daudt AD; Sanvitto JP; Pitrez PM; Pinto LA
    J Bras Pneumol; 2012; 38(6):786-96. PubMed ID: 23288126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases.
    Kudoh S
    Am J Med; 2004 Nov; 117 Suppl 9A():12S-19S. PubMed ID: 15586559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.